SCIENTURE HOLDINGS, INC. Litigation Settlement, Expense
SCIENTURE HOLDINGS, INC. (SCNX) reported Litigation Settlement, Expense of $117.81 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for the quarter ending 2026-06-30 was $117.81K, a 69.13% decline year-over-year.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for the quarter ending 2026-03-31 was $326.18K, a 30.72% decline year-over-year.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for the quarter ending 2025-12-31 was $199.09K, a 70.59% decline year-over-year.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for the quarter ending 2025-09-30 was $1.02M, a 64.52% increase year-over-year.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for fiscal 2025 was $2.07M, a 14.57% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for fiscal 2024 was $1.81M, a 19.92% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for fiscal 2023 was $1.51M, a 81.61% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. litigation settlement, expense for fiscal 2022 was $829.75K, a 18.91% increase from fiscal 2021.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 3 month as first filed | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 6 month as first filed | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 9 month as first filed | Litigation Settlement, Expense 12 month | Litigation Settlement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $117.81K 10-Q · filed 2026-08-13 | $443.99K 10-Q · filed 2026-08-13 | $643.09K derived: sum of 3 quarters · filed 2026-08-13 | $1.66M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $326.18K 10-Q · filed 2026-05-15 | $525.27K derived: sum of 2 quarters · filed 2026-05-15 | $1.54M derived: sum of 3 quarters · filed 2026-05-15 | $1.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $199.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.22M derived: sum of 2 quarters · filed 2026-03-30 | $1.60M derived: sum of 3 quarters · filed 2026-08-13 | $2.07M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-12 | $1.40M derived: sum of 2 quarters · filed 2026-08-13 | $1.87M 10-Q · filed 2025-11-12 | $2.55M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $381.68K 10-Q · filed 2026-08-13 | $852.51K 10-Q · filed 2026-08-13 | $1.53M derived: sum of 3 quarters · filed 2026-08-13 | $2.15M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $470.82K 10-Q · filed 2026-05-15 | $1.15M derived: sum of 2 quarters · filed 2026-05-15 | $1.77M derived: sum of 3 quarters · filed 2026-05-15 | $1.94M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $677.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.30M derived: sum of 2 quarters · filed 2026-03-30 | $1.47M derived: sum of 3 quarters · filed 2026-03-30 | $1.81M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $619.23K 10-Q · filed 2025-11-12 | $790.93K derived: sum of 2 quarters · filed 2025-11-12 | $1.13M 10-Q · filed 2025-11-12 | $1.85M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $171.71K 10-Q · filed 2025-08-12 | $510.75K 10-Q · filed 2025-08-12 | $1.24M derived: sum of 3 quarters · filed 2025-08-12 | $1.64M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $339.05K 10-Q · filed 2025-05-12 | $1.06M derived: sum of 2 quarters · filed 2025-05-12 | $1.47M derived: sum of 3 quarters · filed 2025-05-12 | $1.60M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $724.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.13M derived: sum of 2 quarters · filed 2025-03-26 | $1.26M derived: sum of 3 quarters · filed 2025-03-26 | $1.51M 10-K · filed 2025-03-26 | $1.53M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $409.48K 10-Q · filed 2024-11-06 | $408.96K 10-Q · filed 2024-01-16 | $534.28K derived: sum of 2 quarters · filed 2024-11-06 | $782.50K 10-Q · filed 2024-11-06 | $1.05M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $124.80K 10-Q · filed 2024-08-09 | $193.45K 10-Q · filed 2023-08-18 | $373.01K 10-Q · filed 2024-08-09 | $441.66K 10-Q · filed 2023-08-18 | $635.68K derived: sum of 3 quarters · filed 2024-08-09 | $826.69K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $248.22K 10-Q · filed 2024-06-26 | $248.22K 10-Q · filed 2023-05-15 | $510.88K derived: sum of 2 quarters · filed 2024-06-26 | $701.89K derived: sum of 3 quarters · filed 2024-06-26 | $841.75K derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | $262.67K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $453.67K derived: sum of 2 quarters · filed 2024-04-22 | $593.53K derived: sum of 3 quarters · filed 2024-04-22 | $829.75K 10-K · filed 2024-04-22 | $830.36K 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $191.01K 10-Q · filed 2024-01-16 | $191.61K 10-Q · filed 2022-11-07 | $330.87K derived: sum of 2 quarters · filed 2024-01-16 | $567.09K 10-Q · filed 2024-01-16 | $567.69K 10-Q · filed 2022-11-07 | $802.28K derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-06-30 | $139.86K 10-Q · filed 2023-08-18 | $376.08K 10-Q · filed 2023-08-18 | $611.28K derived: sum of 3 quarters · filed 2023-08-18 | $710.14K derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $236.22K 10-Q · filed 2023-05-15 | $471.42K derived: sum of 2 quarters · filed 2023-05-15 | $570.29K derived: sum of 3 quarters · filed 2023-05-15 | $774.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $235.20K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $334.07K derived: sum of 2 quarters · filed 2023-03-27 | $537.78K derived: sum of 3 quarters · filed 2023-03-27 | $697.83K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $98.87K 10-Q · filed 2022-11-07 | $302.58K derived: sum of 2 quarters · filed 2022-11-07 | $462.63K 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | $203.71K 10-Q · filed 2022-07-25 | $363.76K 10-Q · filed 2022-07-25 | ||||||
| 2021-03-31 | $160.05K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |